<DOC>
	<DOCNO>NCT02213731</DOCNO>
	<brief_summary>The purpose clinical study ass single procedure outcomes use cryoballoon ablation without additional empirical lesion and/or complex fractionate electrogram ( CFE ) ablation patient early persistent atrial fibrillation ( &lt; 1 year first diagnosis persistent AF ) .</brief_summary>
	<brief_title>Cryoballoon Ablation Early Persistent Atrial Fibrillation ( Cryo4 Persistent AF )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients document symptomatic persistent AF refractory intolerant least 1 class I III antiarrhythmic medication . Persistent AF define : Episode lasting longer 7 day , le 1 year document consecutive ECG recording 100 % AF great 7 day apart OR Episode require electrical pharmacological cardioversion 48 hour AF document continuous record Date first diagnosis persistent AF within last 12 month precede consent date Age 18 75 year Willing comply study requirement give inform consent ( define legally effective , documented confirmation subject 's ( legally authorize representative guardian ) voluntary agreement participate particular clinical study ) participate clinical study Longstanding persistent AF ( last ≥1 year ) Current diagnosis paroxysmal AF Anteroposterior LA diameter &gt; 5.0 cm TTE Current intracardiac thrombus Presence one pulmonary vein stent Presence preexist pulmonary vein stenosis Primary pulmonary hypertension NYHA class IV congestive heart failure and/or document leave ventricular ejection fraction ( LVEF ) &lt; 40 % measure acceptable cardiac testing ( e.g . TTE ) Hypertrophic cardiomyopathy Previous LA ablation surgery Unstable angina Presence cardiac valve prosthesis Thrombocytosis , thrombocytopenia Any condition contraindicate chronic anticoagulation Any cardiac surgery , myocardial infarction , PCI / PTCA coronary artery stenting occur 3 month interval precede consent date Any cerebral ischemic event ( stroke TIAs ) occur 6 month interval precede consent date Cryoglobulinemia Presence likely implant permanent pacemaker , biventricular pacemaker , loop recorder , type implantable cardiac defibrillator ( without biventricular pace function ) within 12 month Uncontrolled hyperthyroidism Any woman know pregnant breastfeed Active systemic infection Subject employ Medtronic department investigator close relative investigator Life expectancy ≤ 1 year Currently enrol plan participate potentially confound drug device trial course study . Coenrollment concurrent study allow documented preapproval obtain Medtronic study manager Exclusion criterion per local law ( France , include , limited : incompetent adult patient affiliate French social security system )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Persistent Atrial Fibrillation</keyword>
	<keyword>Cryoablation</keyword>
	<keyword>Cryoballoon</keyword>
	<keyword>Pulmonary Vein Isolation</keyword>
</DOC>